Atlas Trials

A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma

Clinical trial NCT03514407 · TERMINATED

Trial details

NCT number
NCT03514407
Sponsor
Incyte Corporation
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed Ewing Sarcoma
Start date
2018-06-27
Primary completion
2020-06-25
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.